W
Wenjie Mei
Researcher at Guangdong Pharmaceutical University
Publications - 2
Citations - 96
Wenjie Mei is an academic researcher from Guangdong Pharmaceutical University. The author has contributed to research in topics: Metabolic pathway & Glycolysis. The author has an hindex of 2, co-authored 2 publications receiving 60 citations.
Papers
More filters
Journal ArticleDOI
Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-κB/c-Myc pathway.
Lin Jiao,Shengqi Wang,Yifeng Zheng,Neng Wang,Bowen Yang,Dongmei Wang,Depo Yang,Wenjie Mei,Zhimin Zhao,Zhiyu Wang,Zhiyu Wang +10 more
TL;DR: It is shown that BA could inhibit aerobic glycolysis activity in breast cancer cell lines MCF‐7 and MDA‐MB‐231 by hampering lactate production, glucose uptake and extracellular acidification rate (ECAR), as well as suppressing aerobic glyCOlysis‐related proteins including c‐Myc, lactate dehydrogenase A (LDH‐A) and p‐ PDK1/PDK1 (pyruvate dehydrogensase kinase
Journal ArticleDOI
Network-pharmacology-based identification of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis.
Bowen Yang,Neng Wang,Shengqi Wang,Xiong Li,Yifeng Zheng,Min Li,Ju-Xian Song,Fengxue Zhang,Wenjie Mei,Yi Lin,Yi Lin,Zhiyu Wang,Zhiyu Wang +12 more
TL;DR: Investigating the anti-metastasis mechanism of Oldenlandia diffusa in breast cancer proved that EEOD could inhibit breast cancer metastasis by attenuating the expression of Cav-1, highlighting the use of EEOD as an adjunctive therapy for metastatic breast cancer patients.